Paul M. Ridker

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Inflammation and Atherosclerosis

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

Progress and challenges in translating the biology of atherosclerosis

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

From Vulnerable Plaque to Vulnerable Patient

Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention

Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men

Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease

C-Reactive Protein Levels and Outcomes after Statin Therapy